Dawson John Andrew bought PDSB
October 18, 2026 · Form 4 insider transaction
Dawson John Andrew bought 22,700 shares of PDS Biotechnology Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,700
Price
$0.00
Total value
N/A
InsiderDawson John Andrew
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 18, 2026
Filing dateOctober 21, 2026
Shares owned after22,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Stock Option shall vest in three (3) equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such dates.